Clinical Trials Browser

Phase 1/2 × Interventional × SLC-0111 × Clear all

NCT03450018 2024-05-24

SLC-0111-17-01

Phase 1/2 Terminated

Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma